Cytokine profiles in pregnant gilts experimentally infected with porcine reproductive and respiratory syndrome virus and relationships with viral load and fetal outcome. by LADINIG, A. et al.
VETERINARY RESEARCH
Ladinig et al. Veterinary Research  (2014) 45:113 
DOI 10.1186/s13567-014-0113-8RESEARCH Open AccessCytokine profiles in pregnant gilts experimentally
infected with porcine reproductive and respiratory
syndrome virus and relationships with viral load
and fetal outcome
Andrea Ladinig1*, Joan K Lunney2, Carlos JH Souza2,3, Carolyn Ashley1, Graham Plastow4 and John CS Harding1Abstract
In spite of extensive research, immunologic control mechanisms against Porcine Reproductive and Respiratory
Syndrome virus (PRRSv) remain poorly understood. Cytokine responses have been exhaustively studied in nursery
pigs and show contradictory results. Since no detailed reports on cytokine responses to PRRSv in pregnant females
exist, the objectives of this study were to compare host cytokine responses between PRRSv-infected and non-infected
pregnant gilts, and to investigate relationships between cytokine levels in infected gilts and viral load or fetal mortality
rate. Serum samples and supernatants of peripheral blood mononuclear cells (PBMC) either stimulated with PRRSv
or phorbol myristate acetate/Ionomycin (PMA/Iono) were analyzed for cytokines/chemokines: interleukins (IL) 1-beta
(IL1β), IL4, IL8, IL10, IL12, chemokine ligand 2 (CCL2), interferon alpha (IFNα) and interferon gamma (IFNγ). Three
cytokines (IFNα, CCL2, IFNγ) in gilt serum differed significantly in inoculated versus control gilts over time. In
supernatants of PRRSv stimulated PBMC from PRRSv-infected gilts, levels of IFNα were significantly decreased,
while IL8 secretion was significantly increased. PRRSv infection altered the secretion of all measured cytokines,
with the exception of IFNα, from PBMC after mitogen stimulation, indicating a possible immunomodulatory effect
of PRRSv. IFNα, CCL2, and IFNγ in serum, and IFNγ in supernatants of PMA/Iono stimulated PBMC were significantly
associated with viral load in tissues, serum or both. However, only IFNα in supernatants of PRRSv stimulated PBMC was
significantly associated with fetal mortality rate. We conclude that of the eight cytokines tested in this study IFNα was
the best indicator of viral load and severity of reproductive PRRSv infection.Introduction
Cytokines and chemokines play a key role in the regula-
tion of the innate, humoral (T-helper 2 [Th2]) and cellular
(T-helper 1 [Th1]) immune responses [1]. Early cytokines
including the type I interferons and pro-inflammatory
cytokines (interleukins 1 (IL1), IL6 and tumor necrosis
factor-alpha (TNFα)), and late cytokines such as interferon-
gamma (IFNγ), are important regulators of adaptive
immune responses [2]. Two important chemokines are
interleukin 8 (IL8 or CXCL8), a potent recruiter of
neutrophils to sites of infection, and chemokine ligand
2 (CCL2), which induces the migration of monocytes* Correspondence: andrea.ladinig@usask.ca
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unless otherwise stated.from blood to become tissue macrophages [3]. Antiviral
or type I interferons are produced by a variety of cells,
with plasmacytoid dendritic cells (pDC) or interferon
producing cells (IPCs) being specialists in this task [3].
Type II interferon, IFNγ, and IL12 are key inducers of
Th1 immune responses [2,3]. The functions of IL10 are
diverse, but principally aimed at immune regulation
[3,4]. Unlike in human or mouse, in which IL4 is the
major Th2 cytokine [5-7], the role of IL4 in pigs is not
completely clear and its expression in vivo following
viral infection is usually low or undetectable [8-10].
Recently, bead-based multiplex assays, also known as
Fluorescent Microsphere Immunoassays (FMIA), be-
came available for measurement of cytokines in porcine
specimens. FMIA allows high throughput, simultaneous
detection and quantification of multiple analytes and. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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[11,12]. For detection of cytokines, FMIA technology relies
on the availability of capture and detection antibodies
(Abs) enabling specific and sensitive measurement of the
respective analytes. Because a limited number of swine
antibodies are available and not all work well in multiplex
FMIA the use of FMIA to detect swine cytokines is
presently limited [13].
Cytokine responses to Porcine Reproductive and Respira-
tory Syndrome virus (PRRSv) infection have been exhaust-
ively studied using both in vivo and in vitro models. A
thorough review is beyond the scope of the present paper.
However, reports on cytokine responses to PRRSv infection
in vivo contain contradictory results and were mainly
performed in nursery pigs using respiratory models.
Rowland et al. [14] used a reproductive model to inves-
tigate cytokine responses in PRRSv-infected fetuses but
not in dams. To our knowledge, no detailed reports of
cytokine responses to PRRSv infection in pregnant sows
or gilts exist. Therefore, the objectives of the present study
were: 1) to compare host cytokine responses between
PRRSv-infected and non-infected gilts following experi-
mental infection in the third trimester of gestation; 2) to
investigate relationships between cytokine levels and viral
load in gilt serum and gilt tissues; and 3) to investigate
relationships between cytokine levels and fetal mortality
rate defined at the level of the gilt as percent dead fetuses
per litter. Three specific host responses were evaluated
over 19 days post inoculation (dpi): 1) cytokine production
in gilt serum, 2) cytokine production in supernatants
of PRRSv-stimulated peripheral blood mononuclear
cells (PBMC), and 3) cytokine production in supernatants
of phorbol myristate acetate/Ionomycin (PMA/Iono)
stimulated PBMC.
Materials and methods
Animal experiment and sample collection
The experimental infection protocol is described in detail
in Ladinig et al. [15]. Briefly, on experimental day 0 (D0),
114 pregnant Landrace gilts (gestation day 85 ± 1 over 12
biweekly replicates) were inoculated with PRRSv isolate
NVSL 97–7895 (1 × 105 TCID50; 2 mL intramuscular and
1 mL into each nostril) (INOC), while 19 control gilts
were similarly sham inoculated (CTRL). PRRSv negativity
of gilts was confirmed before delivery to the University
of Saskatchewan by ELISA (IDEXX PRRS X3 Ab test,
IDEXX laboratories, Inc., Maine, USA) and PCR (Tetracore
PRRS real-time PCR kit, Tetracore, Inc., Rockville, USA).
Furthermore, all gilts were negative for PRRSv RNA by a
strain-specific in-house quantitative reverse transcrip-
tion polymerase chain reaction (qRT-PCR) in serum
on D0 [15]. Serum and whole blood samples were col-
lected on D0, D2, D6, D19 and D21. On D21 (gestation
day 106 ± 1), gilts were humanely euthanized andnecropsy examinations were performed on gilts and
their fetuses. Fetal preservation status was recorded
and the percent dead fetuses were calculated for each
litter. PRRSv RNA concentrations were measured in
gilt serum and gilt tissue samples (lung, tonsil, repro-
ductive and tracheobronchial lymph node) collected at
termination using qRT-PCR [15]. The experiment was
approved by the University of Saskatchewan’s Animal
Research Ethics Board, and adhered to the Canadian
Council on Animal Care guidelines for humane animal
use (permit #20110102).
PBMC stimulation
PBMC were isolated from whole blood collected on D0, D2,
D6 and D19 by gradient centrifugation using lymphocyte
separation medium (Ficoll-Paque™ PLUS, GE Healthcare).
Cells were re-suspended in RPMI medium 1640 (RPMI)
(Life Technologies, Burlington, ON, Canada) supplemented
with antibiotics (1% Pen/Strep) and 10% fetal bovine serum
(FBS) (Life Technologies, Burlington, ON, Canada). On
the day of isolation, freshly isolated PBMC were seeded
in 48-well tissues culture plates (1 × 106 cells/ well, total
volume 500 μL). Duplicate wells for each stimulation
time point were stimulated with either 10 ng/mL PMA
(Sigma-Aldrich, Oakville, ON, Canada) and 250 ng/mL
ionomycin (Sigma-Aldrich, Oakville, ON, Canada) (PMA/
Iono) or with PRRSv isolate NVSL 97–7895 (multiplicity
of infection =1). Unstimulated cells were seeded in dupli-
cate wells containing cell culture medium only. Plates
were incubated at 37 °C in 5% CO2 for either 36 h (PMA/
Iono stimulation) or 60 h (PRRSv stimulation). Cells and
supernatants from duplicate wells were pooled and centri-
fuged (400 g, 10 min). Supernatant aliquots were stored
frozen at −80 °C until further testing.
Cytokine testing
Serum samples (D0, D2, D6, D21) and PBMC superna-
tants (D0, D2, D6, D19) were analysed for the following
innate, regulatory, Th1 and Th2 cytokines/chemokines
by FMIA: IL1β, IL8, CCL2, IFNα, IL10, IL12, and IL4.
Due to the lack of availability of antibodies suitable for
FMIA, an enzyme-linked immunosorbent assay (ELISA)
was used to measure IFNγ.
Multiplex fluorescent microsphere immunoassay (FMIA)
For serum samples, a 7-plex in-house FMIA assay was
developed as previously described with several modifica-
tions [12]. Beads, standards and Ab pairs used for the
different cytokines are listed in Table 1. Briefly, capture
antibodies were covalently coupled to magnetic beads
(Biorad, Mississauga, ON, Canada). Coupling efficiency
was tested by staining newly coupled beads with goat anti-
mouse IgG-Phycoerythrin labeled Ab (Life Technologies,
Burlington, ON, Canada) and comparing fluorescence
Table 1 Standards, capture and detection antibodies used by FMIA and ELISA
Cytokine (bead region) Standard (source) Capture Ab (source) Detection Ab (source)
IL1β (26) DY681, part 841042 (RD) DY681, part 841040 (RD) BAF 681 (RD)
IL8 (27) SD061 (L) MCA1660 (C) MAB5351 (RD)
CCL2 (53) RP0017S-025 (C) Anti-poCCL2 clone 5–2 (Lu) Anti-poCCL2 clone 18–1 (Lu)
IFNα (45) 17105-1 (C) GTX11408 (GT) 27105-1 (C)
IL10 (28) CSC0103, part SD064 (L) ASC0104 (L) ASC9109 (L)
IL12 (36) DY912, part 841099 (RD) MA0413S-500 (C) BAM9122 (RD)
IL4 (34) CSC1283, part 5S.128.10 (L) CSC1283, part 5S.128.09 (L) ASC0849 (L)
IFNγ (ELISA) CSC4033, part SD066 (L) CSC4033, part ASC4934D (L) CSC4033, part ASC4839D (L)
(RD) R&D Systems, Minneapolis, MN, USA; (L) Life technologies, Burlington, ON, Canada; (C) Cedarlane, Burlington, ON, Canada; (GT) GeneTex, Irvine, CA, USA; (Lu)
Lunney lab, Beltsville, MD, USA (Lunney et al., manuscript in preparation).
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Figure 1 Examples of standard curves obtained by FMIA
and ELISA. Examples of standard curves of recombinant protein
standards serially diluted in serum (A) or cell culture medium
(B) for the seven cytokines tested by FMIA; (C) examples of
IFNγ-standard curves (recombinant protein serially diluted) in
serum (ser) or cell culture medium (sup) by ELISA.
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(generously provided by Dr C. Souza, USDA, Beltsville,
MD, USA). Serum from a healthy, non-infected gilt with
no measurable levels of relevant cytokines by FMIA was
used to prepare serial dilutions of cytokine standards
(Figure 1A). The same serum was used as negative control
on each FMIA plate. All serum samples were tested at a
1:3 dilution in phosphate buffered saline (PBS, pH 7.4)
supplemented with 1% bovine serum albumin (BSA) and
0.05% sodium azide (PBS-BN). Samples and standards
were incubated with magnetic beads in duplicate wells of
a 96-well plate for 2 h. All incubations were performed in
the dark (aluminum foil cover) at room temperature on a
rotating plate shaker (500 rpm). A 96-well plate washer
(Bio-Plex Pro™ II Wash Station, Biorad, Mississauga, ON,
Canada) was used to perform 3 washes with PBS +0.05%
Tween 20 (PBST) after each incubation step. Fifty μL
of anti-cytokine, biotinylated, secondary antibody (Ab)
diluted in PBS-BN were added to each well and plates
were incubated for 90 min. The optimal concentration
of each biotinylated detection Ab was determined by
titration. Finally, beads in each well were incubated in
50 μL of a solution containing 10 ug/mL of Strepavidin-
R-Phycoerythrin (SAPE, PJRS20 Prozyme, Hayward,
CA, USA) for 30 min, washed, and re-suspended in
100 μL PBST. Coupled microspheres were analyzed on a
Bio-Plex® 200 system (Biorad, Mississauga, ON, Canada)
and analyzed with the Bio-Plex Manager software version
6.1 (Biorad, Mississauga, ON, Canada). All mean fluores-
cence intensity (MFI) measurements were background
corrected by subtracting the MFI of the negative control
(control serum diluted 1:3 in PBS-BN) from the MFI for
the relevant analyte in each sample.
PBMC supernatants were tested in a similar manner.
However, due to high cytokine concentrations present
after either PRRSv or PMA/Iono stimulation, a higher
sample dilution was required for certain analytes and use
of a 7-plex assay was therefore not feasible. For superna-
tants of PRRSv stimulated PBMC, CCL2 was analyzed as a
single-plex assay at a 1:100 dilution, while the remaining
Ladinig et al. Veterinary Research  (2014) 45:113 Page 4 of 10analytes were tested in a 6-plex assay at a 1:5 dilution. For
supernatants of PMA/Iono stimulated PBMC, IL-8 was
analyzed at a 1:20 dilution, while the remaining analytes
were tested in a 6-plex assay at a 1:5 dilution. Cell culture
medium (RPMI +10% FBS +1% Pen/Strep) at the relevant
dilution in PBS-BN was used as negative control and to
prepare standard curves (Figure 1B). Biotinylated detec-
tion Abs were titrated in order to determine the optimal
concentration to use in testing PBMC supernatants. Results
from supernatants of PRRSv or PMA/Iono stimulated
PBMC were adjusted by subtracting the cytokine levels in
supernatants of unstimulated cells cultured for the same
time point (36 or 60 h). These are reported as “adjusted”
cytokine values herein.
IFN-γ ELISA
The assay was carried out using the Novex Swine IFNγ
antibody duoset kit (Life Technologies Inc., Burlington,
ON, Canada) according to the manufacturer’s instructions.
Low coefficient of variation (CV) Immulon 4 HBX 96 well
plates (VWR International, Mississauga, ON, Canada) were
coated with capture Ab diluted in Coating Buffer B (Life
Technologies Inc., Burlington, ON, Canada). 5X Assay
Buffer (Novex Antibody Pair Buffer Set, Life Technologies
Inc., Burlington, ON, Canada) diluted in ddH2O was used
as a blocking solution and for dilution of detection and
Streptavidin-HRP Abs and samples as appropriate. Plates
were washed with PBST using a Bio-Plex Pro II Wash
Station. Peroxidase-labeled conjugates were detected by the
addition of SureBlue Reserve TMB Microwell Substrate
(Mandel Scientific Company Inc, Guelph, ON, Canada).
Color was developed in the dark until the optical density of
the highest standard reached approximately 2.0 at a wave-
length of 650 nm without addition of Stop Solution. Plates
were read in a Vmax Microplate Reader (Molecular Devices
Corporation, Downingtown, PA, USA) using SoftMaxPro
software Version 1.1 (Sunnyvale, CA, USA). The standard
curve (1000 pg/mL to 8 pg/mL) was constructed using
doubling dilutions (Figure 1C). Concentrations of IFNγ in
samples were estimated by comparison with a 4-parameter
standard curve generated by the software. Serum samples
were diluted 1:3 in assay buffer whereas the standard dilu-
ent was a 1:3 solution of control gilt serum in assay buffer.
Supernatants of PRRSv and PMA/Iono stimulated PBMC
were tested at 1:3 and 1:100 dilutions, respectively, in assay
buffer. The standard diluent was a corresponding dilution
of cell culture medium in assay buffer. As above, IFNγ
levels in PBMC supernatants were adjusted by subtracting
the IFNγ levels in supernatants of unstimulated cells;
adjusted IFNγ values are compared and reported herein.
Cytokine quality control (QC)
Protein standards (Table 1) were used to prepare high
and low concentration quality controls in either controlserum or cell culture media at the relevant dilution in
PBS-BN. Both high and low quality controls were run in
duplicate on each FMIA and ELISA plate. Process behavior
control charts were used to monitor the inter-plate vari-
ation of each cytokine concentration in the QC samples, as
well as the MFI of the highest and lowest standard on each
FMIA plate. Plates were repeated if values fluctuated above
or below the 3-sigma natural process limits on the appro-
priate control charts. Individual samples were repeated if
the replicate CV was >20% as calculated by the instrument’s
software.
Statistical analysis
Separate statistical analyses were conducted using Stata
13 (STATA Corp, College Station, Texas, USA) to address
each of three objectives. To meet the key model assump-
tions, data were transformed (logarithm base10 or zero-
skewness (lnskew0 function in STATA)) as appropriate.
First, to determine if cytokine levels differed between
INOC and CTRL gilts, multilevel mixed-effects linear
regression models were developed. These models used gilt
as a random effect and accounted for repeated measures
by day. All remaining analyses used data from INOC gilts
only and specifically focused on the cytokines that differed
statistically between INOC and CTRL gilts. Our second
objective was to determine potential relationships between
cytokine levels (serum and supernatants) and PRRS viral
load in serum and tissues. For these analyses, multilevel
mixed-effects linear regression models controlling for
experimental replicate were used. The area under the
curve (AUC) for PRRSv RNA (target copies/μL, D0-D21)
and cytokine protein (pg/mL) in serum (D0-D21) and
supernatants (D0-D19) over time was calculated using the
formula AUC = (t1-t0)(a1 + a0)/2 + (t2-t1)(a1 + a2)/2 +… +
(tn-tn-1)(an-1 + an)/2. Our third objective was to determine
potential associations between cytokine levels in serum
(AUC) and fetal survival rate (percentage of dead fetuses
per litter). For all analyses, cytokine levels in sera or
adjusted cytokine levels in supernatants (as described
above) were used.
To account for multiple comparisons, all associations
were considered statistically significant if P < 0.01. All final
models were evaluated to ensure normality and homosce-
dasticity of residuals.
Results
Cytokine differences between inoculated and control gilts
Examples of standard curves of recombinant protein
standards serially diluted in either serum or cell culture
medium for the seven cytokines tested by FMIA are pre-
sented in Figures 1A and 1B. Examples of standard curves
for the IFNγ ELISA are presented in Figure 1C.
Cytokine levels showed a high degree of variation
between individual gilts in all sample types (Additional
Ladinig et al. Veterinary Research  (2014) 45:113 Page 5 of 10file 1, Additional file 2 and Additional file 3). Serum levels
of CCL2, IFNα and IFNγ differed significantly between
INOC and CTRL gilts over time (P < 0.001 for all). INOC
gilts showed a significant increase in CCL2 and IFNα in
sera collected on D2 and D6, whereas IFNγ was increased
significantly on D2 only (Figure 2). IFNγ levels measured
in serum of INOC gilts on D21 were lower than CTRL
gilts; however, differences were not statistically significant.
High serum levels of IL1β and IL8 at all 4 time points
were measured in individual INOC and CTRL gilts, but
PRRSv inoculation had no effect on these analytes over
time (Additional file 1). Levels of IL12, IL10 and IL4 were
very low in serum of both INOC and CTRL gilts and did
not significantly differ over time (Additional file 1).0
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Figure 2 CCL2, IFNα and IFNγ levels in gilt serum over time.
Mean (± SEM) CCL2 (A), IFNα (B) and IFNγ (C) levels in serum from
111 INOC and 19 CTRL gilts across respective study days; P-values
indicate significant differences between INOC and CTRL gilts on
individual days.In supernatants of PRRSv stimulated PBMC, levels of
IFNα and IL8 differed significantly between INOC and
CTRL gilts over time (P ≤ 0.001). PRRSv stimulation
induced high levels of IFNα in PBMC from CTRL gilts
and from INOC gilts before inoculation. Levels of IFNα
were highly variable, ranging from 62 to 17025 pg/mL.
A significant reduction in IFNα was detected in stimu-
lated PBMC from INOC gilts compared to CTRL on D2,
D6, and D19 (Figure 3A). Decreased levels were detected
in all INOC gilts but to varying degrees. IL8 levels in
supernatants of PRRSv stimulated PBMC were signifi-
cantly increased on D2, D6, and D19 in INOC versus
CTRL gilts (Figure 3B). Levels of IL1β, CCL2, IFNγ, IL4,
IL10 and IL12 in supernatants of PRRSv stimulated
PBMC were either not detectable or low, and did not
significantly differ between INOC and CTRL gilts over
time (Additional file 2).
IFNα was not induced by PMA/Iono stimulation. All
other cytokines from PMA/Iono stimulated PBMC differed
between INOC and CTRL gilts over time (P < 0.001 for all
except IFNγ where only a trend was reported (P = 0.039))
(Additional file 3). Among the 7 cytokines measured, four
discrete patterns were observed reflecting the potential
effects of gilt PRRSv infection on PBMC PMA/Iono-12000
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Figure 3 Adjusted IFNα and IL8 levels in supernatants of PRRSv
stimulated PBMC over time. Mean (± SEM) adjusted IFNα (A) and
IL8 (B) levels in supernatants of PRRSv stimulated PBMC from 111
INOC and 19 CTRL gilts across respective study days. P-values indicate
significant differences between INOC and CTRL gilts on individual days.
Adjusted cytokine levels were calculated by subtracting values in
supernatants of unstimulated cells from PRRSv stimulated cells.
Ladinig et al. Veterinary Research  (2014) 45:113 Page 6 of 10responsiveness. First, PRRSv infection resulted in a signifi-
cantly increased CCL2 response to PMA/Iono stimulation
on D2 and D6 but not on D19 (early induction; Figure 4A).
These statistical differences however, are the result of a
single outlier CTRL gilt with massive spontaneous pro-
duction of CCL2 from unstimulated PBMC on day 2.
With this outlier removed, CCL2 production significantly
differed between INOC and CTRL over time (P = 0.01)
with levels in INOC increased on D2 and D6 compared
to CTRL. After adjusting for multiple comparison this
was considered a trend (D2 P = 0.027, D6 P = 0.019). By
contrast, levels of IL8, IL10, and IL12 were significantly
decreased on D2 in INOC compared to CTRL gilts (early
suppression; Figures 4B-D). Following PMA/Iono stimula-
tion, levels of IL1β decreased similarly on D2, but were0
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adjusted CCL2 (A), IL8 (B), IL10 (C), IL12 (D), IL1β (E), and IL4 (F) levels in s
CTRL gilts across respective study days. P-values indicate significant differen
cytokine levels were calculated by subtracting values in supernatants of unsignificantly increased in PBMC from INOC versus CTRL
gilts on D6 (early suppression with rebound; Figure 4E).
Finally, IL4 demonstrated late suppression with levels
from PMA/Iono stimulated PBMC significantly decreased
in INOC versus CTRL on D19. Prior to D19, IL4 levels
numerically increased in INOC gilts (Figure 4F). Similarly,
IFNγ levels decreased in INOC gilts on D19; however, dif-
ferences were not significant but rather a trend (P = 0.023;
Additional file 3).
Relationships between cytokines levels and PRRS viral load
Detailed results on viral loads in gilt serum and tissues
can be found in Ladinig et al. [15]. Briefly, all INOC gilts
were viremic on D2 and D6, and 94/111 (84.7%) remained
viremic until termination. The percentage of tissues that0
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from INOC gilts were 90.1 (lung), 99.1 (tonsil), 100 (re-
productive lymph node), and 99.1 (tracheobronchial
lymph node), respectively. The mean viral loads of positive
samples were 3.5 (±1.2) log10 RNA copies/mg in lung, 5.6
(±0.8) log10 RNA copies/mg in tonsil, 5.8 (±0.8) log10
RNA copies/mg in reproductive lymph node, and 4.8
(±0.9) log10 RNA copies/mg in tracheobronchial lymph
node. AUC of IFNα and CCL2 in serum were positively
associated with the AUC for viral load in serum (Table 2,
Figures 5A and B). As shown in Figure 5, this association
was mainly driven by gilts with high cytokine levels and
high viral load over time, represented in the upper right
quadrant. Importantly, no gilts had high cytokine levels
but low viral loads over time (lower right quadrant). A
positive association was detected between the AUC for
CCL2 in serum and the viral load in lung. IFNα levels in
serum trended to be positively associated with viral load
in tonsil, while IFNγ levels showed a significant, but nega-
tive association (Table 2). No associations could be found
for cytokine levels in serum with viral load in tracheo-
bronchial lymph node. Although none of the cytokines
measured in supernatants of PRRSv stimulated PBMC
were associated with viral load in serum or tissues, levels
of IFNγ in supernatants of PMA/Iono stimulated PBMC
showed a negative association with viral load in reproduct-
ive lymph node (Table 2).
Relationships between cytokines and fetal mortality rate
In INOC gilts, the percentage of dead fetuses 21 days post
inoculation varied from 0% to 94.4% (mean 41.0 ± 22.8%).
AUC of IFNα in supernatants of PRRSv stimulated PBMC
was significantly associated with percent dead (β = 0.001,
P = 0.006) (Figure 5C), similarly AUC of IFNα in
serum trended to be positively associated with fetal
death (β = 0.0035, P = 0.060). For cytokine levels inTable 2 Associations between cytokine levels and viral load i
pregnant gilts
PRRSv RNA concentration
(log10/μL or mg)
Serum cytokine levels (AUC)
IFNα CCL2
Serum (AUC) P = 0.003 P < 0.001
β = 0.002134 β = 0.0001
Lung ns P = 0.010
β = 0.0000
Tonsil P = 0.016 ns
β = 0.000185
Repro LN ns ns
The associations between cytokine levels over time (represented as area under curv
(regression coefficients, β) were obtained by univariate, multilevel mixed-effects reg
with viral load in either serum or any of the tested tissues are included. No associat
and viral load. Repro LN = reproductive lymph node. PMA/Iono supernatant AUC = A
infected gilts. ns = not significant (P > 0.01).supernatants, a negative trend was detected between
the AUC of IL10 in PMA/Iono stimulated PBMC and
percent dead fetuses (β = −0.001, P = 0.045). For the
remaining analytes, levels in serum or in supernatants
were not associated with fetal death.
Discussion
The results presented herein are part of an extensive
and complex dataset obtained in a large scale, multi-
institutional project aimed at finding phenotypic and
genotypic predictors of PRRSv resistance in pregnant gilts.
The objectives of this present study were to investigate
cytokine responses in serum and supernatants of PBMC,
either stimulated with PRRSv or a nonspecific mitogen
(PMA/Iono), and to determine possible associations with
the outcome of infection in a reproductive model. In order
to investigate genotypic variation in the severity of repro-
ductive PRRS, a large number of gilts were experimentally
inoculated in the third trimester of gestation, while the
number of CTRL gilts was reduced to the minimum
needed to provide baseline data.
PMA, a diester of phorbol and potent tumor promoter
which activates the signal transduction enzyme protein
kinase C, is often used in conjunction with ionomycin,
an ionophore inducing calcium transport into the cell, in
order to stimulate immune responses in vitro [3,16]. In
the present experiment, PMA/Iono stimulation of PBMC
induced the secretion of all cytokines tested with the
exception of IFNα. Four distinct patterns were observed
in the way PRRSv infection altered PBMC cytokine secre-
tions after PMA/Iono stimulation. The altered secretion
of cytokines by PMA/Iono stimulated PBMC from INOC
gilts after infection indicates a PRRSv immunomodulatory
effect. However, the biological meaning of these findings
is difficult to interpret. When testing the associations
between cytokine levels in supernatants of PMA/Ionon serum and tissues following PRRSv infection in
PMA/Iono supernatant (AUC)
IFNγ IFNγ
ns ns
04
ns ns
10
P < 0.001 ns
β = −0.000115
ns P = 0.002
β = −0.0000004
e (AUC)) and viral load in gilt serum and tissues are presented. P-values
ression models. Only analytes that were found to be significantly associated
ion was found among cytokines in supernatants of PRRSv stimulated PBMC
UC of IFNγ levels secreted from PMA/Iono stimulated PBMC from PRRSv
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Figure 5 Scatter plots of selected cytokines in serum and supernatants of PRRSv stimulated PBMC versus viral load in gilt serum or
percent dead fetuses per litter. The levels of IFNα (A) and CCL2 (B) in serum over time are plotted against the viral load in gilt serum over
time (area under the curve (AUC) from 0 to 21 dpi) illustrating individual variation. (C) The levels of IFNα in supernatants of PRRSv stimulated
PBMC over time (AUC) are plotted against the percentage of dead fetuses per litter. Animals in the upper right quadrant are helping to drive the
relationship. No gilts had high cytokine levels and low viral load in serum or low percent of dead fetuses per litter.
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only significant association was between IFNγ and viral
load in reproductive lymph node, where higher levels of
IFNγ were associated with a lower viral burden.
Serum IFNγ levels were significantly increased in INOC
gilts early in infection. This finding agrees with several
reports of either numeric or significant increases in the
number of IFNγ secreting cells by enzyme-linked immu-
nospot (ELISPOT) assay, or in the protein levels measured
in serum of pigs after PRRSv inoculation [12,17-24]. IFNγ
levels in supernatants of PRRSv stimulated PBMC also
showed a slight increase on D2, which was not statistically
significant. Unlike IFNα and CCL2, no association was
found between IFNγ levels in serum and viral load in gilt
serum over time. On the other hand, viral loads in tonsil
were negatively associated with IFNγ levels in serumindicating a possible protective effect of IFNγ. However,
IFNγ levels over time were not associated with fetal death.
In contrast, Lowe et al. [25] showed that a strong cell
mediated immune response determined by use of an IFNγ
ELISPOT was correlated with protection against repro-
ductive PRRS in 3 of 4 investigated farms.
The present study found IFNα to be one of the most
relevant cytokines in PRRSv infection. High levels of IFNα
were produced by PRRSv stimulated PBMC from CTRL
gilts and INOC gilts before inoculation, which is in
contrast to previous reports [26,27]. IFNα production,
however, was significantly decreased in PBMC collected at
all time points following PRRSv inoculation. The levels of
IFNα in supernatants of PRRSv stimulated PBMC were
positively associated with fetal mortality. Interestingly, it
was previously demonstrated that North American type
Ladinig et al. Veterinary Research  (2014) 45:113 Page 9 of 10PRRS viruses are potent inhibitors of type 1 interferon
production in pDC [28], which are a major source of
IFNα and play a key role in the early control of virus
replication and the development of adaptive antiviral
immune responses [29]. By contrast, a recent study showed
that various type 1 and type 2 PRRSv strains induced IFNα
secretion by pDC and showed either no or only weak
suppression of IFNα secretion [27]. These recent data
corroborate our findings of increased levels of IFNα in
serum from INOC gilts. However, results of IFNα mea-
surements in serum from PRRSv infected pigs are quite
inconsistent. While some studies could not detect signifi-
cant IFNα increases in serum of PRRSv inoculated pigs
within one week of infection [12,18], others did [19,30].
Increased levels of IFNα might have negative effects in
regards to PRRSv infection, since it was previously shown
that IFNα up-regulated the expression of sialoadhesin and
therefore enhanced PRRSv infection of monocytes [31].
In agreement with our results, Souza et al. [32] found
significant increases in serum IFNα and CCL2 levels of
nursery piglets within the first 2 weeks after inoculation
with PRRSv 97–7895, the same virus strain as used for
this study. IFNα and CCL2 levels in serum were also
associated with PRRSv RNA concentration and growth
performance where piglets with low concentration in
serum showed a faster return to basal levels of IFNα and
CCL2 in serum compared to highly viremic animals.
Although we demonstrate the biological importance of
INFα in the reproductive PRRSv model herein, the
relevance of CCL2 responses in reproductive PRRS is
questionable. Although serum CCL2 levels were positively
associated with viral burden in serum and lung tissue in
the present study, no association was detected between
CCL2 levels and fetal death. We propose the role of
CCL2 in PRRSv infection primarily involves monocyte
recruitment in lung, and is unrelated to mechanisms of
fetal death or survival.
Although IL8 levels significantly increased in superna-
tants of PRRSv stimulated PBMC from INOC gilts after
infection, this finding did not have any biological relevance
as IL8 levels were not associated with any measured
outcome, including PRRSv viral levels or fetal mortality
rate. In agreement with previous reports [12,19], no
significant increase in serum IL8 levels was detected in
INOC compared to CTRL gilts.
In conclusion, PRRSv infection increased IFNα, CCL2,
and IFNγ levels in serum but only before 7 dpi. Viral load
in gilt serum was positively associated with serum IFNα
and CCL2 levels. Although CCL2 and IFNγ were not
associated with fetal outcome, IFNα levels in serum
trended to be positively associated with fetal mortality
rate. The importance of IFNα in regards to PRRSv infec-
tion was demonstrated by the significant inhibition of
IFNα secretion by PRRSv stimulated PBMC from INOCgilts after infection, and a significant positive association
between fetal mortality rate and levels of IFNα in superna-
tants from PRRSv stimulated PBMC. Therefore, IFNα
secretion could be used as a possible indicator of viral load
and severity of reproductive PRRS. By contrast, IL8 was
not associated with viral load or fetal death even though
IL8 secretion by PRRSv stimulated PBMC from INOC
gilts was significantly increased at all investigated time
points after infection. Finally, levels of IFNγ in superna-
tants of PMA/Iono stimulated PBMC were suppressed by
21 days post-inoculation, and were negatively associated
with viral load in reproductive lymph node. Together
with the fact that IFNγ levels in serum were negatively
associated with viral load in tonsil, this suggests a pro-
tective effect of IFNγ in PRRSv pathogenesis.
Additional files
Additional file 1: Mean cytokine levels (SD) in serum. Mean cytokine
(SD) levels in serum are presented for the 8 analysed cytokines from 111
INOC and 19 CTRL gilts on respective study days post inoculation. If the
repeated measures, multilevel mixed-effects regression model demonstrated
values in INOC significantly differed from CTRL gilts over all experimental
days (DAY*INOC), group differences on individual days were compared
(INOC_CTRL). Due to multiple comparisons, P < 0.01 was considered
statistically significant. ns = not significant.
Additional file 2: Mean cytokine levels (SD) in supernatants of
unstimulated and PRRSv stimulated PBMC. Mean (SD) cytokine levels in
supernatants of unstimulated and PRRSv stimulated PBMC are presented for
the 8 analysed cytokines from 111 INOC and 19 CTRL gilts on the respective
study days post inoculation. Adjusted values were calculated by subtracting
values in supernatants of unstimulated cells from PRRS stimulated cells and
used in statistical analyses. Statistics determined whether values in INOC
significantly differed from CTRL gilts over all experimental days (DAY*INOC),
or on individual days (INOC_CTRL). Due to multiple comparisons, P < 0.01
was considered statistically significant; ns = not significant.
Additional file 3: Mean cytokine levels (SD) in supernatants of
unstimulated and PMA/Iono stimulated PBMC. Mean (SD) cytokine
levels in supernatants of unstimulated and phorbol myristate acetate/
Ionomycin (PMA/Iono) stimulated PBMC are presented for the 8 analysed
cytokines from 111 INOC and 19 CTRL gilts on the respective study days
post inoculation. Adjusted values were calculated by subtracting values
in supernatants of unstimulated cells from PMA/Iono stimulated cells and
used in statistical analyses. Statistics determined whether values in INOC
significantly differed from CTRL gilts over all experimental days (DAY*INOC)
or on individual days (INOC_CTRL). Due to multiple comparisons, P < 0.01
was considered statistically significant. ns = not significant.
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